<a href="https://www.fiercebiotech.com/biotech/us-taps-small-san-diego-biotech-experimental-ebola-treatment-epidemic-worsens" hreflang="en">US taps small San Diego biotech for experimental Ebola treatment as epidemic worsens</a>
fiercebiotech.com·May 20, 2026
The U.S. government has enlisted a San Diego biotech company to supply doses of an experimental antibody to combat the worsening Ebola outbreak in central Africa.
The key learning here for someone interested in biotech and healthtech is the strategic importance of niche biotech companies in addressing global health crises, highlighting potential opportunities for small biotechs to collaborate with government agencies on high-impact projects. This underscores the value of investing in or partnering with companies that have unique capabilities in infectious disease therapeutics.